Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for COMPASS Pathways PLC Sponsored ADR (CMPS : NSDQ)
 
 • Company Description   
COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK.

Number of Employees: 156

 
 • Price / Volume Information   
Yesterday's Closing Price: $11.81 Daily Weekly Monthly
20 Day Moving Average: 4,329,213 shares
Shares Outstanding: 134.95 (millions)
Market Capitalization: $1,593.75 (millions)
Beta: 2.39
52 Week High: $12.24
52 Week Low: $2.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 29.07% 22.77%
12 Week 61.12% 48.95%
Year To Date 71.16% 54.43%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
33 Broadwick Street
-
London,X0 W1F 0DQ
GBR
ph: +1-716-676-6461
fax: -
ir@compasspathways.com https://compasspathways.com
 
 • General Corporate Information   
Officers
Kabir Nath - ChiefExecutiveOfficer
Gino Santini - Chairman
Teri Loxam - Chief Financial Officer
Justin Gover - Director
Robert McQuade - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 20451W101
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 07/30/26
Share - Related Items
Shares Outstanding: 134.95
Most Recent Split Date: (:1)
Beta: 2.39
Market Capitalization: $1,593.75 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.51 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.24 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/30/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.88
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 31.82%
vs. Previous Quarter: 49.15%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/26 - -31.07
12/31/25 - -192.95
09/30/25 - -111.18
ROA
03/31/26 - -11.40
12/31/25 - -61.31
09/30/25 - -56.55
Current Ratio
03/31/26 - 3.32
12/31/25 - 0.77
09/30/25 - 1.23
Quick Ratio
03/31/26 - 3.32
12/31/25 - 0.77
09/30/25 - 1.23
Operating Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Net Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Pre-Tax Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Book Value
03/31/26 - 2.42
12/31/25 - -0.55
09/30/25 - 0.39
Inventory Turnover
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Equity
03/31/26 - 0.15
12/31/25 - -
09/30/25 - 0.49
Debt-to-Capital
03/31/26 - 13.38
12/31/25 - -
09/30/25 - 33.10
 

Powered by Zacks Investment Research ©